|
|
histone modification
|
GO:0016570 |
159 |
0.992
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.991
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.986
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.978
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.889
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.857
|
|
|
|
histone h2a ubiquitination
|
GO:0033522 |
3 |
0.845
|
|
|
|
protein dealkylation
|
GO:0008214 |
13 |
0.845
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.726
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.715
|
|
|
|
histone demethylation
|
GO:0016577 |
13 |
0.707
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.688
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.684
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.681
|
|
|
|
protein demethylation
|
GO:0006482 |
13 |
0.673
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.645
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.636
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.582
|
|
|
|
histone h3 k36 demethylation
|
GO:0070544 |
2 |
0.576
|
|
|
|
histone h2a monoubiquitination
|
GO:0035518 |
1 |
0.568
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.541
|
|
|
|
demethylation
|
GO:0070988 |
23 |
0.507
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.476
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.453
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.423
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.400
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.387
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.384
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.373
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.369
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.313
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.304
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.285
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.276
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.275
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.264
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.262
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.240
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.235
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.223
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.220
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.220
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.220
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.213
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.211
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.207
|
|
|
|
histone monoubiquitination
|
GO:0010390 |
3 |
0.199
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.199
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.194
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.188
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.184
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.182
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.179
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.178
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.175
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.172
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.166
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.165
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.165
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.161
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.157
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.154
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.152
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.151
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.146
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.145
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.143
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.139
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.136
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.135
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.133
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.132
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.130
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.130
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.128
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.128
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.127
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.125
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.124
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.123
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.122
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.120
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.118
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.116
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.115
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.115
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.115
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.110
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.110
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.109
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.108
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.108
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.107
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.106
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.105
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.103
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.102
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.102
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.100
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.095
|
Human |
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.095
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.095
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.093
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.092
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.091
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.090
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.090
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.089
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.086
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.086
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.086
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.085
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.083
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.078
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.078
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.076
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.075
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.075
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.075
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.073
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.072
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.071
|
|
|
|
histone ubiquitination
|
GO:0016574 |
10 |
0.071
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.071
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.071
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.070
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.070
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.070
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.069
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.069
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.068
|
|
|
|
regulation of histone h3 k36 methylation
|
GO:0000414 |
1 |
0.067
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.067
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.066
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.065
|
Human |
|
|
gonad development
|
GO:0008406 |
141 |
0.064
|
|
|
|
histone h3 k27 demethylation
|
GO:0071557 |
4 |
0.064
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.062
|
Human |
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.061
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.060
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.060
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.058
|
|
|
|
histone h3 k36 methylation
|
GO:0010452 |
6 |
0.057
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.057
|
Human |
|
|
b cell activation
|
GO:0042113 |
161 |
0.057
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.057
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.056
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.056
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.056
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.056
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.055
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.054
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.054
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.054
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.053
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.053
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.052
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.052
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.052
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.052
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.051
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.051
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.051
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.051
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.051
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.050
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.050
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.049
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.049
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.048
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.048
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.048
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.047
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.046
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.045
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.045
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.045
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.045
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.045
|
Human |
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.045
|
|
|
|
snrna metabolic process
|
GO:0016073 |
1 |
0.044
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.043
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.043
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.042
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.042
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.042
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.042
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.041
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.041
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.040
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.040
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.040
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.039
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.038
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.037
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.037
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.036
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.036
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.036
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.036
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.036
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.036
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.035
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.035
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.035
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.034
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.034
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.034
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.034
|
|
|
|
negative regulation of transcription from rna polymerase i promoter
|
GO:0016479 |
2 |
0.034
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.033
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.033
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.033
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.033
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.033
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.033
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.033
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.033
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.033
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.032
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.032
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.032
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.032
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.032
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.031
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.031
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.031
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.031
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.030
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.029
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.029
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.029
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.029
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.029
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.029
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.028
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.028
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.028
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.028
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.028
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.028
|
|
|
|
histone h3 k9 demethylation
|
GO:0033169 |
5 |
0.028
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.028
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.028
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.028
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.027
|
Human |
|
|
chemotaxis
|
GO:0006935 |
247 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.027
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.027
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.027
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.027
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.027
|
Human |
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.026
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
12 |
0.026
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.026
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.026
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.026
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.026
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.026
|
|
|
|
cellular response to sterol
|
GO:0036315 |
2 |
0.026
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.025
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.025
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.025
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.025
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.025
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.025
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.025
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.024
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.024
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.024
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.024
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.024
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.024
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.024
|
Human |
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.024
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.023
|
|
|
|
positive regulation of t cell differentiation in thymus
|
GO:0033089 |
13 |
0.023
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.023
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.023
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.023
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.023
|
|
|
|
lateral ventricle development
|
GO:0021670 |
11 |
0.023
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.022
|
Human |
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.022
|
|
|
|
memory
|
GO:0007613 |
58 |
0.022
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.022
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.022
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.022
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.022
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.022
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.021
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.021
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.021
|
|
|
|
snrna processing
|
GO:0016180 |
1 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.021
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.021
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.021
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.020
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.020
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.020
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.020
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
protein monoubiquitination
|
GO:0006513 |
11 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.020
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.020
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.020
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.019
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.019
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.019
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.019
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.019
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.019
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.018
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.018
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.018
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.018
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.018
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.018
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.017
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.017
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.017
|
Human |
|
|
bone mineralization
|
GO:0030282 |
54 |
0.017
|
|
|
|
snrna 3 end processing
|
GO:0034472 |
1 |
0.017
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.017
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.017
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.017
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.017
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.017
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.017
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.016
|
Human |
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.016
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.016
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.016
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.016
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.016
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.016
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.016
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.016
|
|
|
|
positive regulation of retinoic acid receptor signaling pathway
|
GO:0048386 |
3 |
0.016
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.016
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.015
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.015
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.015
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.015
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.015
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.015
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.015
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.015
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.015
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.015
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.015
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.015
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.015
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.015
|
|
|
|
spliceosomal complex disassembly
|
GO:0000390 |
1 |
0.015
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
9 |
0.014
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.014
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.014
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.014
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.014
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.014
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.014
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.014
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.014
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.014
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.014
|
|
|
|
negative regulation of circadian rhythm
|
GO:0042754 |
8 |
0.014
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.014
|
|
|
|
mitotic spindle checkpoint
|
GO:0071174 |
9 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.013
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.013
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.013
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
|
positive regulation of immature t cell proliferation in thymus
|
GO:0033092 |
3 |
0.013
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.013
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.013
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.013
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.013
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.013
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.013
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.013
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.012
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.012
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.012
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.012
|
|
|
|
negative regulation of dna recombination
|
GO:0045910 |
13 |
0.012
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.012
|
|
|
|
signal transduction downstream of smoothened
|
GO:0007227 |
4 |
0.012
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.012
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|